Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

RTTNews | Před 762 dny
Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

(RTTNews) - Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday that the company expects to resubmit its New Drug Application (NDA) for vadadustat as a treatment for anemia due to chronic kidney disease in adult patients on dialysis by the end of the third quarter of 2023.

Upon acceptance of the NDA, Akebia expects the U.S. Food and Drug Administration (FDA) to set a PDUFA date of six months from the date of submission.

Akebia received Meeting Minutes summarizing the productive and informative discussion held during an End of Dispute Type A meeting with the FDA in July 2023. The minutes reflect Akebia's plan for the NDA resubmission discussed at the meeting.

Vadadustat is currently approved for use in 34 countries.

For More Such Health News, visit rttnews.com

read more
Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
RTTNews | Před 727 dny
European Shares Set To Follow Wall Street Lower

European Shares Set To Follow Wall Street Lower

European stocks may drift lower at open on Wednesday after U.S. stock markets retreated from record highs overnight on apprehensions about the outlook for interest-rate cuts.
RTTNews | Před 3 h 24 min
Japan Private Sector Growth Weakest In 4 Months

Japan Private Sector Growth Weakest In 4 Months

Japan's private sector grew at the slowest pace in four months in September as the strong rise in services activity was partially offset by a steeper fall in manufacturing production, flash survey data published by S&P Global showed on Wednesday. The flash composite output index fell to 51.1 in September from a six-month high of 52.0 in August.
RTTNews | Před 3 h 54 min
Sensex, Nifty Extend Losses For Fourth Day

Sensex, Nifty Extend Losses For Fourth Day

Indian shares opened on a sluggish note on Wednesday after U.S. President Donald Trump accused India and China of being the primary funders of Russia's war in Ukraine through their continued purchase of Russian oil.
RTTNews | Před 4 h 10 min
Australian Market Doubles Early Losses In Mid-market

Australian Market Doubles Early Losses In Mid-market

The Australian stock market is doubling its early losses in mid-market moves on Wednesday, snapping a three-session winning streak, with the benchmark S&P/ASX 200 falling below the 8,800 level, following the broadly negative cues from Wall Street overnight, with weakness in gold miners, financial and technology stocks partially offset by gains in iron ore miners and energy stocks.
RTTNews | Před 5 h 39 min
Asian Markets Track Wall Street Lower

Asian Markets Track Wall Street Lower

Asian stock markets are mostly lower on Wednesday, following the negative cues from Wall Street overnight, amid rising ambiguity over the outlook for interest rates after US Fed Chair Jerome Powell gave little indication about the future path of interest rates. Renewed trade tensions with the United States and the escalating tensions in Europe and the Middle East are weighing on market sentiment.
RTTNews | Před 5 h 56 min